SEC Form 4 · accession 0000874015-15-000059
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brett P Monia
Officer — SVP, Antisense Drug Discovery
Period of report
Jun 8, 2015
Accepted (ET)
Jun 10, 2015 · 6:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 8, 2015 | M | 7,600 | $10.29 | A | 12,026 | D | |
| Common StockF1 | Jun 8, 2015 | S | 7,600 | $66.221 | D | 4,426 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $10.29 | Jun 8, 2015 | M | 7,600 | D | Jan 3, 2015 | Jan 2, 2018 | Common Stock | 7,600 | 0 | D |
Explanation of responses
- F1Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 5/8/2015.